English▷ renew

The 32nd Annual Meeting of the Japanese Society for Alternatives to Animal Experiments


Toward Innovative Technologies for Universal Alternatives to Animal Experiments


Wednesday, November 20, to Friday November 22, 2019


The National institute of Advanced Industrial Science and Technology(AIST)
1-1-1 Higashi, Tsukuba, Ibaraki 305-8561, Japan


Toshiyuki Kanamori, National Institute of Advanced Industrial Science and Technology



  • Toshiyuki Kanamori, National lnstitute of Advanced lndustrial Science and Technology
  • Tomoo Inomata, Azabu University
  • Noriyasu Imai, KOSE Corporation
  • Hirokazu.Kouzuki, Shiseido Co., Ltd.
  • Yasunari Kanda, National Institute of Health Sciences
  • Hajime Kojima, National Institute of Health Sciences
  • Saito Koichi, Sumitomo Chemical Co., Ltd.
  • Makoto Suzuki, Okinawa Institute of Science and Technology Graduate University
  • Toshiaki Takezawa, National Agriculture and Food Research Organization
  • Kenji Tabata, Astellas Pharma Inc.
  • Kohji Nakazawa, The University of Kitakyushu
  • Junji Fukuda, Yokohama National University
  • Katsuko Furukawa, The University of Tokyo
  • Yamashita Kunihiko, Osaka University


  • Sinji Sugiura, National Institute of Advanced Industrial Science and Technology
  • Takafumi Akahane, Stem Cell Evaluation Technology Research Association
  • Hiroshi Arai, Astellas Pharma Inc.
  • Sosaku Ichikawa, Tsukuba University
  • Michiko Kaneko, National Institute of Advanced Industrial Science and Technology
  • Toshiyuki Kanamori, National Institute of Advanced Industrial Science and Technology
  • Daisuke Kohari, Ibaraki University
  • Takafumi Komori, Eisai Co., Ltd.
  • Yoshiyuki Yamaura, Ono Pharmaceutical Co., Ltd.

Contact to

Secretariat of the 32nd Annual Meeting of JSAAE

KNT-CT Global Travel Co., Ltd.
Rina Kano (Ms.) / Nana Iino (Ms.)
Sumitomo-shoji Kanda-IzumichoBldg., 13F
1-13, Kanda-Izumi-cho, Chiyoda-ku, Tokyo, 101-0024, Japan
Tel: +81-3-6891-9600
Fax: +81-3-6891-9599

Chairman’s Message▷ renew

With the arrival of pleasant weather with spring breezes, we would like to thank you for your continuedassociation with our organization.

The Japanese Society for Alternatives to Animal Experiments (JSAAE) is an academic organization that carries out research, development, education, investigation, etc. for the purpose of establishing and spreading awareness about 3Rs, i.e. Replacement (Methods that avoid or replace the use of animals), Reduction (Methods that minimize the number of animals used per experiment) and Refinement (Methods that minimize animal suffering and improve welfare), a set of international principles for appropriate
implementation of animal testing. These principles have been adopted not only in various countries’national laws and guidelines, but also in international standards and guidelines concerning the welfare ofanimals used in testing. The EU, in its Directive effectuated in March 2013, banned animal testing for thedevelopment of cosmetics products, with its repercussions spreading globally. With regard to chemical substances, the use of alternatives to animal testing is also clearly stipulated in EU’s REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulation and the United States’TSCA (ToxicSubstances Control Act),creating a global trend to adopt testing methods that do not involve animals.International organizations are also reviewing testing methods for pharmaceuticals, medical equipment and agricultural chemicals, with a view to embrace the 3Rs principles. The call for R&D methods that incorporate the 3Rs is encompassing not only cosmetics but also a variety of fields that need to establish safety assurance of chemical products.

In view of this global trend, the JSAAE has decided to hold its 32nd Annual Meeting in Tsukuba City under the main theme of “Toward Innovative Technologies for Universal and Cross-Industrial Alternatives to Animal Experiments.” The development of technologies for establishing alternatives to animal testing is an urgent challenge for the cosmetics industry. At the same time, the pharmaceutical industry is also facing the need to review its conventional drug discovery process due to the skyrocketing cost of R&D and prolonged timeframe for market introduction of developed products. On the other hand, the industry is accelerating its stem cell R&D for therapeutic applications, thereby establishing in-depth understanding of human cells in general and creating various peripheral technologies for handling human cells. The JSAAE’s 32nd Annual Meeting will examine alternatives to animal testing based on the use of human cells and explore their potential as universal technologies that transcend industrial boundaries.

We would appreciate your support for and cooperation with this Annual Meeting with full understanding of its purport.

Chairman of the 32nd Annual Meeting of JSAAE
Toshiyuki Kanamori, Ph.D.
(National lnstitute of Advanced Industrial Science and Technology/AIST)

Submission & Registration▷ renew